• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病与代谢综合征——科学证据及治疗意义

Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.

作者信息

Voiculescu V M, Lupu M, Papagheorghe L, Giurcaneanu C, Micu E

机构信息

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; "Elias" University Emergency Hospital, Bucharest, Romania.

"Elias" University Emergency Hospital, Bucharest, Romania.

出版信息

J Med Life. 2014 Oct-Dec;7(4):468-71.

PMID:25713604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4316120/
Abstract

Psoriasis is a chronic inflammatory disease, predominantly affecting the skin, being included in the group of Immune Mediated Inflammatory Diseases. Growing evidence from the last 10 years suggests that several systemic conditions like metabolic syndrome, cardiovascular disease, diabetes, psychological disorders or inflammatory bowel disease are prevalent in psoriasis patients. The linker might be the chronic secretion of pro-inflammatory cytokines. In this current review, the scientific evidence that explains the relationship between psoriasis and the metabolic syndrome in particular will be addressed, as the metabolic syndrome comprises a group of risk factors for cardiovascular disease, thus offering an overall picture of the systemic involvement in psoriasis. An integrated approach, with an early detection and treatment of the components of the metabolic syndrome, are important steps in psoriasis management. Attention should be paid on influence of psoriasis treatment upon comorbidities and vice-versa.

摘要

银屑病是一种慢性炎症性疾病,主要累及皮肤,属于免疫介导的炎症性疾病范畴。过去10年越来越多的证据表明,银屑病患者中普遍存在几种全身性疾病,如代谢综合征、心血管疾病、糖尿病、心理障碍或炎症性肠病。其中的联系可能在于促炎细胞因子的慢性分泌。在本综述中,将阐述解释银屑病与代谢综合征之间关系的科学证据,因为代谢综合征包含一组心血管疾病的危险因素,从而全面呈现银屑病的全身性病变情况。采用综合方法,早期发现并治疗代谢综合征的各个组成部分,是银屑病管理的重要步骤。应关注银屑病治疗对合并症的影响,反之亦然。

相似文献

1
Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.银屑病与代谢综合征——科学证据及治疗意义
J Med Life. 2014 Oct-Dec;7(4):468-71.
2
[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].[银屑病患者合并症的综合治疗方法。银屑病相关合并症工作组]
Actas Dermosifiliogr. 2012 Jan;103 Suppl 1:1-64. doi: 10.1016/S0001-7310(12)70001-7.
3
[Psoriasis comorbidities].[银屑病共病]
Cas Lek Cesk. 2017 Summer;156(3):119-122.
4
Psoriasis and the metabolic syndrome.银屑病与代谢综合征。
Clin Dermatol. 2018 Jan-Feb;36(1):21-28. doi: 10.1016/j.clindermatol.2017.09.005. Epub 2017 Sep 8.
5
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.银屑病与代谢综合征:对银屑病治疗与管理的启示。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):797-806. doi: 10.1111/jdv.18044. Epub 2022 Mar 14.
6
[Psoriasis: a systemic disease].[银屑病:一种全身性疾病]
Presse Med. 2012 Apr;41(4):338-48. doi: 10.1016/j.lpm.2011.09.026. Epub 2011 Dec 2.
7
Metabolic syndrome and inflammatory skin conditions.代谢综合征与炎症性皮肤疾病。
Curr Opin Pediatr. 2019 Aug;31(4):515-522. doi: 10.1097/MOP.0000000000000790.
8
Psoriasis as a systemic disease.银屑病作为一种全身性疾病。
Clin Dermatol. 2014 May-Jun;32(3):343-50. doi: 10.1016/j.clindermatol.2013.11.001. Epub 2013 Nov 23.
9
[Psoriasis in 2016 : Co-morbidities and therapeutic update].
Rev Med Brux. 2016;37(4):205-209.
10
Evaluation and treatment of metabolic syndrome and cardiovascular disease in adult patients with psoriasis.成年银屑病患者代谢综合征和心血管疾病的评估与治疗
Int J Dermatol. 2023 Dec;62(12):1437-1446. doi: 10.1111/ijd.16873. Epub 2023 Oct 16.

引用本文的文献

1
Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review.芍药总苷在皮肤病中的治疗潜力和药理学见解:综述
Front Pharmacol. 2025 Jan 2;15:1423717. doi: 10.3389/fphar.2024.1423717. eCollection 2024.
2
The Role of Metabolic Syndrome in Psoriasis Treatment Response: A One-Year Comparative Analysis of PASI Progression.代谢综合征在银屑病治疗反应中的作用:一项关于银屑病面积和严重程度指数(PASI)进展的一年期比较分析
Diagnostics (Basel). 2024 Dec 23;14(24):2887. doi: 10.3390/diagnostics14242887.
3
Metabolic Disorders and Psoriasis: Exploring the Role of Nutritional Interventions.代谢紊乱与银屑病:营养干预作用的探索
Nutrients. 2023 Sep 6;15(18):3876. doi: 10.3390/nu15183876.
4
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.替西罗莫司治疗斑块状银屑病和代谢综合征患者的疗效和安全性:RE-SURFACE 1 和 RE-SURFACE 2 研究 5 年数据的事后分析。
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1774-1783. doi: 10.1111/jdv.18167. Epub 2022 Jun 25.
5
Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variations.德国银屑病合并症:基于人群的时空变化研究。
PLoS One. 2022 Mar 22;17(3):e0265741. doi: 10.1371/journal.pone.0265741. eCollection 2022.
6
Identification of Potential Biomarkers of Depression and Network Pharmacology Approach to Investigate the Mechanism of Key Genes and Therapeutic Traditional Chinese Medicine in the Treatment of Depression.抑郁症潜在生物标志物的鉴定及基于网络药理学方法探讨关键基因和治疗抑郁症的中药作用机制
Evid Based Complement Alternat Med. 2021 Dec 31;2021:2165632. doi: 10.1155/2021/2165632. eCollection 2021.
7
Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions.代谢综合征与银屑病:机制及未来方向
Front Immunol. 2021 Jul 23;12:711060. doi: 10.3389/fimmu.2021.711060. eCollection 2021.
8
Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?白细胞介素17(IL - 17)表达是抑郁症和肥胖症发病机制的共同要点吗?
J Clin Med. 2020 Dec 12;9(12):4018. doi: 10.3390/jcm9124018.
9
Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine.我们的选择:一项随机对照试验的研究方案,旨在通过中西医结合优化银屑病治疗的实施。
Trials. 2020 Mar 30;21(1):299. doi: 10.1186/s13063-020-4209-3.
10
Level of inflammatory cytokines tumour necrosis factor α, interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome.代谢综合征背景下银屑病患者体内炎性细胞因子肿瘤坏死因子α、白细胞介素12、23和17的水平
Postepy Dermatol Alergol. 2019 Feb;36(1):70-75. doi: 10.5114/ada.2018.73136. Epub 2019 Feb 2.

本文引用的文献

1
Psoriasis and comorbidities: links and risks.银屑病及其合并症:关联与风险。
Clin Cosmet Investig Dermatol. 2014 Apr 17;7:119-32. doi: 10.2147/CCID.S44843. eCollection 2014.
2
Osteopontin and adiponectin: how far are they related in the complexity of psoriasis?骨桥蛋白和脂联素:在银屑病的复杂性方面,它们的关系有多远?
Arch Dermatol Res. 2013 Dec;305(10):939-44. doi: 10.1007/s00403-013-1392-z. Epub 2013 Jul 25.
3
Leptin levels in patients with psoriasis: a meta-analysis.银屑病患者瘦素水平的 Meta 分析。
Clin Exp Dermatol. 2013 Jul;38(5):478-83. doi: 10.1111/ced.12171.
4
Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.氧化应激与银屑病:肿瘤坏死因子-α抑制剂治疗的影响。
Br J Dermatol. 2013 May;168(5):984-9. doi: 10.1111/bjd.12144.
5
Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.银屑病与代谢综合征:观察性研究的系统评价和荟萃分析。
J Am Acad Dermatol. 2013 Apr;68(4):654-662. doi: 10.1016/j.jaad.2012.08.015. Epub 2013 Jan 27.
6
The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies.银屑病与肥胖的相关性:观察性研究的系统评价和荟萃分析。
Nutr Diabetes. 2012 Dec 3;2(12):e54. doi: 10.1038/nutd.2012.26.
7
The association between psoriasis and dyslipidaemia: a systematic review.银屑病与血脂异常的相关性:系统评价。
Br J Dermatol. 2013 Mar;168(3):486-95. doi: 10.1111/bjd.12101. Epub 2013 Jan 18.
8
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.全球银屑病流行病学:发病率和患病率的系统评价。
J Invest Dermatol. 2013 Feb;133(2):377-85. doi: 10.1038/jid.2012.339. Epub 2012 Sep 27.
9
The relationship between oxidative stress, smoking and the clinical severity of psoriasis.氧化应激、吸烟与银屑病临床严重程度的关系。
J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e370-5. doi: 10.1111/j.1468-3083.2012.04700.x. Epub 2012 Sep 25.
10
Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.银屑病患者患糖尿病的风险增加及接受糖尿病治疗的可能性
Arch Dermatol. 2012 Sep;148(9):995-1000. doi: 10.1001/archdermatol.2012.1401.